A Study of Chemotherapy and Ramucirumab vs. Chemotherapy Alone in Second Line Non-small Cell Lung Cancer Patients Who Received Prior First Line Platinum Based Chemotherapy
 
Sponsors and Collaborators
Eli Lilly and Company
ImClone LLC
 
Contact
1-877-CTLILLY (1-877-285-4559)
1-317-615-4559
 
Investigator
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon – Fri 9AM – 5PM Eastern time (UTC/GMT – 5 hours, EST)
 
ClinicalTrials.gov Identifier